LILLY ELI & CO: management transactions · United States · SEC (Form 4) Browse the full directors' dealings record of LILLY ELI & CO, a listed issuer based in United States. Shares are quoted on US US, under the oversight of SEC (Form 4). Market capitalisation: €1,015.5bn. The latest transaction was disclosed on 8 February 2016 (Cession). Among the most active insiders: Fry Stephen F. Every trade is accessible without an account.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Last declaration on 8 February 2016
All Executives55 Thresholds0 Prospectus0 Other0
Declarations 55 total
▼ SVP, HR & Diversity · Executives · 5 Feb 2016
15,230 shares Common Stock SEC:0000059478-16-000318:0
◇ Chief Eth/Cmpl Ofcr & SVP, ERM · Executives · 1 Feb 2016
2,072 shares Common Stock SEC:0000059478-16-000288:0
● Chief Eth/Cmpl Ofcr & SVP, ERM · Executives · 1 Feb 2016
656 shares Common Stock SEC:0000059478-16-000288:1
◇ Sr. VP & Pres., Lilly Diabetes · Executives · 1 Feb 2016
10,360 shares Common Stock SEC:0000059478-16-000290:0
● Sr. VP & Pres., Lilly Diabetes · Executives · 1 Feb 2016
4,872 shares Common Stock SEC:0000059478-16-000290:1
◇ President, Mfg. Operations · Executives · 1 Feb 2016
7,252 shares Common Stock SEC:0000059478-16-000292:0
● President, Mfg. Operations · Executives · 1 Feb 2016
3,307 shares Common Stock SEC:0000059478-16-000292:1
▼ SVP, HR & Diversity · Executives · 1 Feb 2016
2,412 shares Common Stock SEC:0000059478-16-000294:2
▼ SVP, HR & Diversity · Executives · 3 Feb 2016
725 shares Common Stock SEC:0000059478-16-000294:3
◇ Senior VP and General Counsel · Executives · 1 Feb 2016
9,066 shares Common Stock SEC:0000059478-16-000296:0
● Senior VP and General Counsel · Executives · 1 Feb 2016
4,194 shares Common Stock SEC:0000059478-16-000296:1
◇ Chairman, President and CEO · Executives · 1 Feb 2016
46,623 shares Common Stock SEC:0000059478-16-000298:0
● Chairman, President and CEO · Executives · 1 Feb 2016
21,923 shares Common Stock SEC:0000059478-16-000298:1
◇ EVP,Science&Tech and Pres. LRL · Executives · 1 Feb 2016
15,541 shares Common Stock SEC:0000059478-16-000300:0
● EVP,Science&Tech and Pres. LRL · Executives · 1 Feb 2016
7,308 shares Common Stock SEC:0000059478-16-000300:1
◇ SVP & Pres., Lilly Oncology · Executives · 1 Feb 2016
9,843 shares Common Stock SEC:0000059478-16-000302:0
● SVP & Pres., Lilly Oncology · Executives · 1 Feb 2016
4,629 shares Common Stock SEC:0000059478-16-000302:1
◇ Sr. VP, Corp. Affairs & Comm. · Executives · 1 Feb 2016
5,698 shares Common Stock SEC:0000059478-16-000304:0
● Sr. VP, Corp. Affairs & Comm. · Executives · 1 Feb 2016
2,680 shares Common Stock SEC:0000059478-16-000304:1
◇ EVP-Global Services and CFO · Executives · 1 Feb 2016
19,685 shares Common Stock SEC:0000059478-16-000306:0
● EVP-Global Services and CFO · Executives · 1 Feb 2016
9,146 shares Common Stock SEC:0000059478-16-000306:1
▼ EVP-Global Services and CFO · Executives · 1 Feb 2016
6,546 shares Common Stock SEC:0000059478-16-000306:2
▼ EVP-Global Services and CFO · Executives · 3 Feb 2016
3,937 shares Common Stock SEC:0000059478-16-000306:3
◇ SVP and Pres, Lilly Bio-Meds · Executives · 1 Feb 2016
9,843 shares Common Stock SEC:0000059478-16-000308:0
● SVP and Pres, Lilly Bio-Meds · Executives · 1 Feb 2016
4,656 shares Common Stock SEC:0000059478-16-000308:1
25 of 55 declarations
Load more (30 remaining)